Table 1 Demographics and clinical characteristics of the included patients
Patients (n = 100) | |
|---|---|
Age [Median (IQR)] | 36 (29.5- 44) |
Sex | |
Males [n (%)] | 27 (27%) |
Females [n (%)] | 73 (73%) |
BMI [Median (IQR)] | 26.12 (23.42- 29.4) |
Age at onset of migraine [Median (IQR)] | 25 (20- 32) |
Type of Migraine | |
Episodic [n (%)] | 69 (69%) |
Chronic [n (%)] | 31 (31%) |
Aura | |
With aura [n (%)] | 32 (32%) |
Without aura [n (%)] | 68 (68%) |
Frequency of migraine attacks/ month [Median (IQR)] | 8 (4 - 20) |
VAS [Median (IQR)] | 7 (5-8) |
Duration of untreated attack in hours [Median (IQR)] | 6 (4- 24) |
Abortive treatment | |
Paracetamol [n (%)] | 32 (32%) |
NSAIDs [n (%)] | 31 (31%) |
Triptans [n (%)] | 19 (19%) |
Combined [n (%)] | 18 (18%) |
Response to Abortive treatment | |
Good [n (%)] | 35 (35%) |
Moderate [n (%)] | 40 (40%) |
Poor [n (%)] | 25 (25%) |
Age at onset of IBS [Median (IQR)] | 24 (20- 30) |
Type of IBS | |
Constipation -predominant [n (%)] | 36 (36%) |
Diarrhea -predominant [n (%)] | 10 (10%) |
Unclassified -IBS [n (%)] | 25 (25%) |
Mixed -diarrhea-and-constipation [n (%)] | 29 (29%) |
IBS severity scoring system [Median (IQR)] | 300 (222.5- 400) |